At a glance
- Originator GlaxoSmithKline
- Class
- Mechanism of Action Serotonin 4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Irritable bowel syndrome
Most Recent Events
- 16 Dec 1999 No-Development-Reported for Irritable bowel syndrome in United Kingdom (PO)
- 24 Apr 1996 New profile
- 24 Apr 1996 Preclinical development for Irritable bowel syndrome in United Kingdom (PO)